Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Pro-Dex Inc. | 15 | 0 | 0 | 0 | €16.80 | - | - |
| Enlivex Therapeutics Ltd. | 1 | 0 | 1 | 0 | €1.46 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €69.50 | €100.00 | 43.885% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €40.60 | €46.19 | 13.756% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.00 | €23.46 | 67.599% |
| Drägerwerk AG & Co. KGaA ST | 2 | 0 | 0 | 0 | €44.20 | - | - |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
| Bastide Le Confort | 1 | 0 | 1 | 0 | €18.60 | - | - |
| Verastem Inc. | 9 | 0 | 0 | 0 | €10.20 | €27.03 | 165.010% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.75 | €4.39 | 150.645% |
| US Physical Therapy Inc. | 7 | 1 | 0 | 0 | €94.00 | €108.77 | 15.711% |
| Patterson Companies Inc. | 6 | 0 | 0 | 0 | €23.80 | €32.18 | 35.219% |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | €61.00 | €83.81 | 37.401% |
| Brookdale Sr Lvg | 2 | 0 | 1 | 0 | €6.50 | €8.27 | 27.274% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.21 | - | - |
| Clinica Baviera S.A. | 2 | 0 | 0 | 0 | €28.60 | - | - |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €18.33 | €28.17 | 53.670% |
| Owens & Minor Inc. | 2 | 1 | 0 | 0 | €22.20 | €24.04 | 8.298% |
| Codexis Inc. | 5 | 2 | 1 | 0 | €3.65 | €8.36 | 129.161% |
| Radnet Inc. | 7 | 3 | 0 | 0 | €47.60 | €50.90 | 6.926% |
| Glycomimetics Inc. | 5 | 0 | 0 | 0 | €1.71 | €7.35 | 330.926% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.72 | €4.63 | 541.177% |
| Intra-Cellular Therapies Inc. | 23 | 0 | 7 | 0 | €64.00 | €79.43 | 24.109% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.28 | €3.60 | 181.840% |